Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)
$2.9800
-0.0200 ( -1.06% ) 7.6K
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
Market Data
Open
$2.9800
Previous close
$3.0000
Volume
7.6K
Market cap
$202.76M
Day range
$3.0100 - $3.1750
52 week range
$2.2800 - $19.0500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 12 | May 31, 2024 |
4 | Insider transactions | 1 | May 30, 2024 |
8-k | 8K-related | 17 | May 29, 2024 |
8-k | 8K-related | 13 | May 20, 2024 |
10-q | Quarterly Reports | 75 | May 15, 2024 |
8-k | 8K-related | 13 | May 15, 2024 |
4 | Insider transactions | 1 | Apr 24, 2024 |
def | Proxies and info statements | 5 | Apr 18, 2024 |
8-k | 8K-related | 12 | Apr 16, 2024 |
8-k | 8K-related | 12 | Apr 08, 2024 |